International Journal of Hyperthermia 2021 [Link] Parisa Malekzadeh, Meghan Good, Marybeth S Hughes Abstract Introduction: Malignant peritoneal mesothelioma (MPM) is a lethal cancer, with approximately 2% of diagnoses occurring in patients less than 40 years of age. The purpose of this study is to report the only long-term follow up and survival of pediatric patients…

Read More

World Journal of Surgical Oncology 2021 June 5 [Link] Suryanarayana Deo, Mukurdipi Ray, Babul Bansal, Sandeep Bhoriwal, Sushma Bhatnagar, Rakesh Garg, Nishkarsh Gupta, Atul Sharma, Lalit Kumar, Sanjay Thulkar, Ekta Dhamija, Sandeep Mathur, Prasenjit Das Abstract Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has recently emerged as a viable management option for peritoneal…

Read More

Annals of Surgery 2021 June 4 [Link] Vignesh Raman, Soraya L Voigt, Oliver K Jawitz, Norma E Farrow, Kristen E Rhodin, Chi-Fu Jeffrey Yang, Betty C Tong, Thomas A D’Amico, David H Harpole Abstract Background: The outcomes associated with receipt of adjuvant radiation in patients following surgery for malignant pleural mesothelioma (MPM) are poorly understood.…

Read More

Journal of Clinical Medicine 2021 May 26 [Link] Pietro Bertoglio, Elena Garelli, Jury Brandolini, Kenji Kawamukai, Filippo Antonacci, Sara Ricciardi, Alessandro Cipolli, Barbara Bonfanti, Sergio Nicola Forti Parri, Niccolò Daddi, Giampiero Dolci, Piergiorgio Solli Abstract Mesothelioma is an aggressive disease arising from parietal pleura. Surgery is a valuable option in the frame of a multimodality…

Read More

General Thoracic Cardiovascular Surgery 2021 May 24 [Link] Fumihiro Tanaka, Masaru Takenaka, Naoko Imanishi, Ayako Hirai, Masatoshi Kanayama, Masataka Mori, Hiroki Matsumiya, Akihiro Taira, Shinji Shinohara, Koji Kuroda Abstract Objective: Pleurectomy/decortication has been preferably employed as a curative-intent surgery for malignant pleural mesothelioma. However, visceral pleurectomy during pleurectomy/decortication provides technical challenges. For visceral pleurectomy, pleural…

Read More

Journal of Thoracic Disease 2021 April [Link] Sven Oliver Schumann, Gregor Kocher, Fabrizio Minervini Abstract The malignant pleural mesothelioma is a very aggressive tumor which is arising from mesothelial cells and is associated with asbestos exposure. It is a heterogeneous cancer that shows a complex pattern of molecular changes, including genetic, chromosomic, and epigenetic abnormalities.…

Read More

Translational Lung Cancer Research 2021 April [Link] Gerard G Hanna, Thomas John, David L Ball Abstract Malignant pleural mesothelioma is an uncommon thoracic cancer with a relatively poor outcome, which has only seen modest improvements when compared to non-small cell lung cancer. The mainstays of treatment have been surgery and systemic therapy, with radiation reserved…

Read More

Lung Cancer 2021 June [Link] Frédéric Larose, Nicholas Quigley, Yves Lacasse, Simon Martel, Loïc Lang-Lazdunski Abstract Objectives: Medical management based on palliative chemotherapy is currently the standard of care in malignant pleural mesothelioma (MPM). Median survival of 12-16 months has been reported with modern chemotherapy regimens with or without anti-angiogenic agents. Multimodality therapy incorporating cytoreductive…

Read More

Interactive Cardiovascular and Thoracic Surgery 2021 May 8 [Link] Toru Nakamichi, Masaki Hashimoto, Akifumi Nakamura, Ayumi Kuroda, Takashi Tanaka, Jiro Takeuchi, Seiji Matsumoto, Takeshi Morimoto, Nobuyuki Kondo, Kazuhisa Domen, Seiki Hasegawa Abstract Objectives: Impact of pleurectomy/decortication (P/D) on quality of life (QOL) is not widely reported. We investigated QOL and lung function after P/D. Methods:…

Read More